Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice

Molecular Therapy

Volumn 4, Issue 2, 2001, Pages 122-129

  Stoll, Stephanie M ^a   Sclimenti, Christopher R ^a   Baba, Edward J ^a   Meuse, Leonard ^a   Kay, Mark A ^a   Calos, Michele P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epstein Barr virus; Gene therapy; Genomic DNA; Liver; Long term expression; Naked DNA; Non viral vector; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; CIS ACTING ELEMENT; EPSTEIN BARR VIRUS ANTIGEN; PLASMID DNA; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL DIVISION; CHROMOSOME REPLICATION; CONTROLLED STUDY; DNA VECTOR; EMBRYO CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENE THERAPY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VIVO STUDY; KIDNEY CELL CULTURE; LIVER CELL; MAMMAL CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; TAIL; TARGET CELL; TISSUE CULTURE CELL;

EID: 0034882655     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0429     Document Type: Article

References (43)

1. α1-antitrypsin deficiency
2. Gene therapy-promises, problems and prospects
3. Therapeutic serum concentrations of human α-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes
4. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA
5. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
6. Long-term expression of human α1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure
7. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
8. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
9. A putative origin of replication of plasmids derived from Epstein-Barr is composed of two cis-acting components
10. Trans-Activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1
11. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector
12. Isolation of human sequences that replicate autonomously in human cells
13. Autonomous DNA replication in human cells is affected by the size and source of the DNA
14. Epstein-Barr virus-based vectors that replicate in rodent cells
15. The potential of extrachromosomal replicating vectors for gene therapy
16. Stable expression and cell-specific chromatin structure of human α1-antitrypsin cosmid transgenes in rat hepatoma cells
17. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
18. Replication control of autonomously replicating sequences
19. Transcription inhibits the replication of autonomously replicating plasmids in human cells
20. Long-term gene expression from autonomously replicating vectors in mammalian cells
21. Principles of therapeutic liver repopulation
22. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids
23. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: Comparison of two different Epstein-Barr virus-based vectors
24. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes
25. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice
26. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer
27. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo
28. Rat growth hormone gene introns stimulate nucleosome alignment in vitro and in transgenic mice
29. Heterologous introns can enhance expression of transgenes in mice
30. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro
31. Tissue specific expression of the human α-1-antitrypsin gene in transgenic mice
32. Neonatal hepatitis induced by α1-antitrypsin: A transgenic mouse model
33. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver
34. 1-antitrypsin with negligible toxicity
35. Sustained secretion of human α-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
36. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells
37. Human artificial episomal chromosomes for cloning large DNA fragments in human cells
38. Stable episomal maintenance of yeast artificial chromosomes in human cells
39. Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells
40. Epstein-Barr virus vectors for gene expression and transfer
41. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
42. Selective extraction of polyoma DNA from infected mouse cultures
43. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system